These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10029660)

  • 1. Expression of the Cell Adhesion Molecule CD44 in Human Lung Tumors and Cell Lines.
    Resnick NM; Clarke MR; Siegfried JM; Landreneau R; Asman DC; Ge L; Kierstead LS; Dougherty GD; Cooper DL
    Mol Diagn; 1998 Jun; 3(2):93-103. PubMed ID: 10029660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
    Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes.
    Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
    Am J Pathol; 1998 May; 152(5):1157-60. PubMed ID: 9588883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD44 variant isoforms in malignant melanoma.
    Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
    Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule.
    Huerta S; Srivatsan ES; Venkatesan N; Peters J; Moatamed F; Renner S; Livingston EH
    Surgery; 2001 Nov; 130(5):834-43. PubMed ID: 11685193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative Detection of Abnormal CD44 Transcripts in Colon Carcinomas by Reverse Transcription-Polymerase Chain Reaction Enzyme-linked Immunosorbant Assay (RT-PCR ELISA).
    Yoshida K; Goodison S; Sugino T; Bolodeoku J; Churchman M; Warren BF; Tarin D
    Mol Diagn; 1996 Sep; 1(3):167-173. PubMed ID: 10462557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.
    Goodison S; Yoshida K; Sugino T; Woodman A; Gorham H; Bolodeoku J; Kaufmann M; Tarin D
    Cancer Res; 1997 Aug; 57(15):3140-4. PubMed ID: 9242440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression.
    Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J
    Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
    Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
    Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
    Aogi K; Kitahara K; Urquidi V; Tarin D; Goodison S
    Clin Cancer Res; 1999 Oct; 5(10):2790-7. PubMed ID: 10537343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
    Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
    Shimbori M; Kijima H; Sato S; Yoshida H; Sato T; Terasaki-Fukuzawa Y; Onoda N; Kanabuchi K; Abe Y; Nakamura M; Hattori M; Ohno E; Kuramoto H
    Anticancer Res; 2003; 23(1A):115-21. PubMed ID: 12680202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.
    Mikami T; Saegusa M; Mitomi H; Yanagisawa N; Ichinoe M; Okayasu I
    Am J Clin Pathol; 2001 Sep; 116(3):369-76. PubMed ID: 11554165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
    Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
    Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.